Home / Compare / Retatrutide vs Semaglutide
Retatrutide vs Semaglutide
Retatrutide vs Semaglutide: how they work, doses used, FDA status and trial weight loss (28.3% vs 14.9%), with sources.
| Retatrutide | Semaglutide | |
|---|---|---|
| Works on | GIP + GLP-1 + glucagon (triple agonist) | GLP-1 only |
| How it is taken | Injection, once weekly | Injection weekly (Ozempic, Wegovy) or daily tablet |
| US status | Phase 3, not approved (filing planned early 2027) | FDA-approved (2017 diabetes, 2021 weight) |
| Highest dose | 12 mg weekly (highest trial dose) | 2.4 mg weekly, or 7.2 mg (Wegovy HD, 2026) |
| Key trial | TRIUMPH-1 (phase 3) | STEP 1 (phase 3) |
| Average weight loss | 28.3% at 80 weeks (12 mg weekly) | 14.9% at 68 weeks (2.4 mg weekly) |
| Placebo in that trial | not stated in our source | 2.4% |
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.
How they differ
Retatrutide works on gip + glp-1 + glucagon (triple agonist); Semaglutide works on glp-1 only. Retatrutide is taken as: injection, once weekly.Semaglutide is taken as: injection weekly (ozempic, wegovy) or daily tablet.
Dose schedules and warnings: Retatrutide dosage chart ยท Semaglutide dosage chart.
Questions
- Is retatrutide stronger than semaglutide?
- No trial has compared them directly. In separate trials, Retatrutide averaged 28.3% weight loss (TRIUMPH-1 (phase 3), 80 weeks) and Semaglutide 14.9% (STEP 1 (phase 3), 68 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
- Is retatrutide FDA-approved?
- Phase 3, not approved (filing planned early 2027).
- Is semaglutide FDA-approved?
- FDA-approved (2017 diabetes, 2021 weight).
Sources
- AJMC: Retatrutide achieves up to 30.3% average weight loss in phase 3 TRIUMPH-1
- Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021
Last checked 2026-11-16. How we pick and check sources: methodology.